m-Trifluoromethyl-diphenyl diselenide (m-CF3-PhSe)2 modulates the hippocampal neurotoxic adaptations and abolishes a depressive-like phenotype in a short-term morphine withdrawal in mice

التفاصيل البيبلوغرافية
العنوان: m-Trifluoromethyl-diphenyl diselenide (m-CF3-PhSe)2 modulates the hippocampal neurotoxic adaptations and abolishes a depressive-like phenotype in a short-term morphine withdrawal in mice
المؤلفون: Cristina W. Nogueira, Gilson Zeni, Suzan Gonçalves Rosa, Ana M. S. Recchi, Carolina Cristovão Martins
المصدر: Progress in Neuro-Psychopharmacology and Biological Psychiatry. 98:109803
بيانات النشر: Elsevier BV, 2020.
سنة النشر: 2020
مصطلحات موضوعية: Pharmacology, medicine.medical_specialty, biology, business.industry, Hippocampus, Tropomyosin receptor kinase B, Hippocampal formation, CREB, medicine.disease_cause, Neuroprotection, 030227 psychiatry, 03 medical and health sciences, 0302 clinical medicine, Endocrinology, Internal medicine, medicine, biology.protein, Morphine, NMDA receptor, business, Biological Psychiatry, Oxidative stress, medicine.drug
الوصف: The opioid withdrawal syndrome is defined as a complex phenomenon involving multiple cellular adaptations, which leads to the emergence of aversive physical and affective signs. The m-trifluoromethyl-diphenyl diselenide (m-CF3-PhSe)2 elicits an antidepressant-like effect by modulating the opioid system in different animal models of mood disorders. Notably, repeated exposure to (m-CF3-PhSe)2 developed neither tolerance nor withdrawal signs in mice. The aim of the present study was to investigate whether (m-CF3-PhSe)2 attenuates the physical signs and the depressive-like phenotype during morphine withdrawal through its neuroprotective effects on oxidative stress, the NMDA receptor and the proBDNF/mBDNF signaling in the hippocampus of mice. Adult Swiss mice received saline solution or escalating doses (20–100 mg/kg, sc) of morphine for six days. For the next three days, the animals were treated with canola oil, (m-CF3-PhSe)2 (5 and 10 mg/kg, ig) or methadone (5 mg/kg, sc) whereas morphine injections were discontinued. On day 9, physical withdrawal signs and depressive-like behavior were assessed 30 min after the last administration of (m-CF3-PhSe)2. Although short-term treatment with (m-CF3-PhSe)2 at both doses suppressed the aversive physical and affective signs in morphine withdrawn-mice, the highest dose of (m-CF3-PhSe)2 per se increased the teeth chattering manifestation. The intrinsic antioxidant property of (m-CF3-PhSe)2 modulated oxidative stress, it also restored the NMDA receptor levels in the hippocampus of morphine withdrawn-mice. Besides, (m-CF3-PhSe)2 downregulated the proBDNF/p-75NTR/JNK pro-apoptotic pathway without affecting the mBDNF/TrkB/ERK/CREB pro-survival signaling in the hippocampus of morphine withdrawn-mice. The results show that (m-CF3-PhSe)2 treatment modulated the hippocampal neurotoxic adaptations and abolished the depressive-like phenotype following morphine withdrawal in mice.
تدمد: 0278-5846
DOI: 10.1016/j.pnpbp.2019.109803
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::1074de0d487e6e95e8f6fee86483064a
https://doi.org/10.1016/j.pnpbp.2019.109803
Rights: OPEN
رقم الانضمام: edsair.doi...........1074de0d487e6e95e8f6fee86483064a
قاعدة البيانات: OpenAIRE
الوصف
تدمد:02785846
DOI:10.1016/j.pnpbp.2019.109803